AzTrials
AzTrials

Healthy LifestyleNCT05714852

Promotion of Healthy Eating Behaviors in Type 2 Diabetes Patients

A study testing Healthy eating in people with Healthy Lifestyle and Diabetes, run by University of Valencia at 1 site in Spain.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Intervention designed to promote healthy eating in patients with type 2 diabetes. Read more about this study

Who is it for?
Ages 50 to 75 years
Conditions the study is for
Healthy Lifestyle, Diabetes
What is being tested?
Healthy eating
Could I receive a placebo?
No, everyone receives an active treatment
How many people
80 participants
Where
1 siteSpain
Study dates
15 Feb 2023to 10 Feb 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 50 to 75 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Age
  • Type 2 diabetes
  • Poor dietary habits

Who cannot join

  • Micro and macro-vascular complications
  • Poor glycemic control
  • Food allergy

Trial locations and contacts

1 site in 1 country.

Spain1 site, 1 recruiting
  • University hospital valencia

    Valencia, 46010

    Antonio cano sanchez, 629308479, antonio.cano@uv.es

    Recruiting

Other trials in Spain

About this study

Intervention designed to promote healthy eating in patients with type 2 diabetes.

Being tested
Healthy eating
Medical subject headings
Diabetes Mellitus

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Healthy eatingBehavioural

    Promotion of healthy eating

Study groups in NCT05714852
Study groupRoleWhat they receive
InterventionExperimentalNot described
Receives: Behavioral: Healthy eating
ControlNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change in plasma triglycerides

    Plasma triglycerides (mmol/L) assessed using chemistry kits on an analyzer platform

    Measured: Before - 16 weeks

  2. Change in blood glucose

    Plasma blood glucose (mmol/L) assessed using chemistry kits on an analyzer platform

    Measured: Before - 16 weeks

Secondary outcomes (1)
  1. Change in waist circumference

    Waist circumference in cm assessed using steel tape

    Measured: Before - 16 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2023
  2. Study start15 Feb 2023
  3. Primary completion10 Feb 2025 (estimated)
  4. Study completion10 Feb 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
80 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05714852
Sponsor's protocol ID
Valencia Hospital Clínico
Status last verified
Jan 2023
First submitted
26 Jan 2023
Last updated
16 May 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Healthy eating in people with Healthy Lifestyle and Diabetes, run by University of Valencia at 1 site in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 May 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Antonio Cano (0034 629308479, antonio.cano@uv.es), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change in plasma triglycerides (time frame: Before - 16 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 May 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in